Syndrome News and Research

RSS

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

The study findings show that the Omicron-dominant fourth wave of COVID-19 reversed the rising SARS-CoV-2 cases and hospitalization trend seen in the previous three waves in South Africa.

25 Feb 2022

Overview of syphilis, gonorrhea and chlamydia cases in non-EU/EEA countries of the WHO's European Region

In their article published in Eurosurveillance, Bozicevic et al. analyzed data on reported cases of syphilis, gonorrhea and chlamydia for the period 2015 to 2019 from 18 non-EU/EEA countries of the World Health Organization's European Region.

25 Feb 2022

ESC Acute CardioVascular Care 2022 to focus on management of cardiac emergencies

Cutting edge management of urgent heart problems will be revealed during ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

25 Feb 2022

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Researchers demonstrated that irrespective of the type of ACT, SARS-CoV-2 infection rates in patients receiving ACT remained comparable to the general population.

25 Feb 2022

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Researchers conducted a comprehensive and systematic analysis of functional SARS-CoV-2 antibody profiles in a controlled randomized trial of severe COVID-19 hospitalized individuals treated with COVID-19 CCP.

25 Feb 2022

Study suggests history of childhood traumas may increase the risk of long COVID

In a new study, researchers found childhood trauma to be a risk factor for post-coronavirus disease.

25 Feb 2022

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

Researchers of WC19EC conducted a rapid systematic literature review to assess the safety, effectiveness, and efficacy of SARS-CoV-2 disinfection methods, including the ozone devices, in schools.

25 Feb 2022

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Researchers evaluated the efficacy of SARS-CoV-2 vaccines made by Pfizer, Jansen, and Moderna against symptomatic and asymptomatic COVID-19 cases.

25 Feb 2022

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Scientists evaluated the incidence and severity of breakthrough SARS-CoV-2 infections among individuals with immune-mediated inflammatory diseases undergoing B cell depleting therapy.

25 Feb 2022

Declining immune responses against SARS-CoV-2 variants in dialysis patients post-vaccination

Researchers examined systemic B and T cell responses 16 weeks after BNT162b2 vaccination, and the potency of vaccine-induce neutralizing antibodies, in hemodialysis patients and healthcare workers with no comorbidities.

25 Feb 2022

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Researchers characterized humoral and SARS-CoV-2 S-specific T cell responses in IBD patients who received two-dose mRNA-based COVID-19 vaccination series.

25 Feb 2022

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Researchers evaluated CMIR in IBD patients following immunization with two doses of COVID-19 vaccine.

25 Feb 2022

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

In a review published in the International Journal of Molecular Sciences, researchers have been reviewing the use of siRNAs to target coronaviruses.

25 Feb 2022

Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers

In a recent peer-reviewed study, posted to the journal Geoscience Frontiers, researchers conducted a systematic meta-analysis on several studies that assessed the viral RNA load of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in effluents, sludge, and biosolids, and found that the prevalence of SARS-CoV-2 RNA is highest in sludge, followed by biosolids and effluent respectively.

25 Feb 2022

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Scientists from the Case Western Reserve University, USA, have recently conducted a study in collaboration with the National Institutes of Health, USA, to investigate the incidence rates and disease severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States before and after the emergence of omicron variant.

24 Feb 2022

Syndrome News and Research

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

Overview of syphilis, gonorrhea and chlamydia cases in non-EU/EEA countries of the WHO's European Region

ESC Acute CardioVascular Care 2022 to focus on management of cardiac emergencies

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Study suggests history of childhood traumas may increase the risk of long COVID

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Declining immune responses against SARS-CoV-2 variants in dialysis patients post-vaccination

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

Should SARS-CoV-2 Omicron be considered a serotype?

COVID-19's impact on the hopes and dreams of Australians

A comparison of COVID-19 vaccines by neutralizing antibody potency

Melatonin as a safe and potentially life-saving treatment for COVID-19

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News